- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Buy the Dip
U.S. Pharmaceuticals & Biotech Buy the Dip
Results
15
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
15 companies
Soleno Therapeutics
Market Cap: US$3.6b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$66.81
7D
-19.9%
1Y
31.0%
Akebia Therapeutics
Market Cap: US$824.6m
A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.
AKBA
US$3.04
7D
-8.4%
1Y
111.1%
Organogenesis Holdings
Market Cap: US$581.0m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$4.48
7D
-8.4%
1Y
66.5%
aTyr Pharma
Market Cap: US$481.1m
A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
ATYR
US$4.66
7D
-10.9%
1Y
150.5%
Fennec Pharmaceuticals
Market Cap: US$228.2m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$7.91
7D
-14.4%
1Y
41.3%
Tiziana Life Sciences
Market Cap: US$210.7m
A biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States.
TLSA
US$1.75
7D
-21.3%
1Y
44.6%
Journey Medical
Market Cap: US$170.6m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.07
7D
-17.2%
1Y
58.9%
ALT5 Sigma
Market Cap: US$132.2m
Provides blockchain-powered technologies worldwide.
ALTS
US$5.48
7D
-8.1%
1Y
104.5%
Spero Therapeutics
Market Cap: US$107.5m
A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.
SPRO
US$1.84
7D
-22.0%
1Y
47.2%
Connect Biopharma Holdings
Market Cap: US$107.0m
A clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States.
CNTB
US$1.81
7D
-20.3%
1Y
72.4%
OKYO Pharma
Market Cap: US$90.6m
A clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.
OKYO
US$2.29
7D
-22.7%
1Y
122.3%
Quince Therapeutics
Market Cap: US$89.7m
A biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.
QNCX
US$1.61
7D
-12.0%
1Y
163.9%
ImmuCell
Market Cap: US$55.3m
An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
ICCC
US$5.90
7D
-11.3%
1Y
61.2%
TAO Synergies
Market Cap: US$29.1m
Owns and operates an AI token.
TAOX
US$6.96
7D
-16.5%
1Y
85.6%
Can B
Market Cap: US$1.7m
Engages in the protection and commercialization of cannabis patents.
CANB
US$0.019
7D
-9.1%
1Y
33.8%